HIV Citation List:  January 7 – January 20, 2009

 

Pubmed Citations:

 

1) Structure, interaction and real-time monitoring of the enzymatic reaction of wild-type APOBEC3G.

Furukawa A, Nagata T, Matsugami A, Habu Y, Sugiyama R, Hayashi F, Kobayashi N, Yokoyama S, Takaku H, Katahira M.

EMBO J. 2009 Jan 15. [Epub ahead of print]

PMID: 19153609 [PubMed - as supplied by publisher]           

 

2) Discovery of Chiral Cyclopropyl Dihydro-Alkylthio-Benzyl-Oxopyrimidine (S-DABO) Derivatives as Potent HIV-1 Reverse Transcriptase Inhibitors with High Activity Against Clinically Relevant Mutants.

Radi M, Maga G, Alongi M, Angeli L, Samuele A, Zanoli S, Bellucci L, Tafi A, Casaluce G, Giorgi G, Armand-Ugon M, Gonzalez E, Esté JA, Baltzinger M, Bec G, Dumas P, Ennifar E, Botta M.

J Med Chem. 2009 Jan 13. [Epub ahead of print]

PMID: 19140683 [PubMed - as supplied by publisher]           

 

3) Evaluation of the anti-HIV activity of natalizumab, an antibody against integrin alpha4.

Pauls E, Ballana E, Moncunill G, Bofill M, Clotet B, Ramo-Tello C, Esté JA.

AIDS. 2009 Jan 14;23(2):266-8.

PMID: 19112691 [PubMed - in process]        

 

4) Acylthiocarbamates as non-nucleoside HIV-1 reverse transcriptase inhibitors: docking studies and ligand-based CoMFA and CoMSIA analyses.

Cichero E, Cesarini S, Spallarossa A, Mosti L, Fossa P.

J Mol Model. 2009 Jan 20. [Epub ahead of print]

PMID: 19153780 [PubMed - as supplied by publisher]           

 

5) Suberoylanilide hydroxamic acid reactivates HIV from latently infected cells.

Contreras X, Schweneker M, Chen CS, McCune JM, Deeks SG, Martin J, Peterlin BM.

J Biol Chem. 2009 Jan 9. [Epub ahead of print]

PMID: 19136668 [PubMed - as supplied by publisher]           

 

6) How binding of small molecule and peptide ligands to HIV-1 TAR alters the RNA motional landscape.

Bardaro MF Jr, Shajani Z, Patora-Komisarska K, Robinson JA, Varani G.

Nucleic Acids Res. 2009 Jan 12. [Epub ahead of print]

PMID: 19139066 [PubMed - as supplied by publisher]           

 

7) miR-198 inhibits HIV-1 gene expression and replication in monocytes and its mechanism of action appears to involve repression of cyclin T1.

Sung TL, Rice AP.

PLoS Pathog. 2009 Jan;5(1):e1000263. Epub 2009 Jan 16.

PMID: 19148268 [PubMed - in process]        

 

8) Catalytic asymmetric synthesis of an HIV integrase inhibitor.

Zhong YL, Krska SW, Zhou H, Reamer RA, Lee J, Sun Y, Askin D.

Org Lett. 2009 Jan 15;11(2):369-72.

PMID: 19099496 [PubMed - in process]        

 

9) Dimer disruption and monomer sequestration by alkyl tripeptides are successful strategies for inhibiting wild-type and multidrug-resistant mutated HIV-1 proteases.

Bannwarth L, Rose T, Dufau L, Vanderesse R, Dumond J, Jamart-Grégoire B, Pannecouque C, De Clercq E, Reboud-Ravaux M.

Biochemistry. 2009 Jan 20;48(2):379-87.

PMID: 19105629 [PubMed - in process]        

 

10) Celebesides A-C and theopapuamides B-D, depsipeptides from an Indonesian sponge that inhibit HIV-1 entry.

Plaza A, Bifulco G, Keffer JL, Lloyd JR, Baker HL, Bewley CA.

J Org Chem. 2009 Jan 16;74(2):504-12.

PMID: 19072692 [PubMed - in process]        

 

ISI Web of Knowledge Citations:

 

11) Structural Characterization, Biological Effects, and Synthetic Studies on Xanthones from Mangosteen (Garcinia mangostana), a Popular Botanical Dietary Supplement

Young-Won Chin, A. Douglas Kinghorn.

Mini Reviews in Organic Chemistry. 2008 Nov;5(4): 355-364.            

·        No Pubmed record

 

12) Sole copy of Z2-type human cytidine deaminase APOBEC3H has inhibitory activity against retrotransposons and HIV-1

Tan L, Sarkis PT, Wang T, Tian C, Yu XF.

FASEB J. 2009 Jan;23(1):279-87.

·        Pubmed link

·        Pubmed ID: 18827027       

 
13) Design and synthesis of 2-(2,6-dibromophenyl)-3-heteroaryl-1,3-thiazolidin-4-ones as anti-HIV agents

Rawal RK, Tripathi R, Katti SB, Pannecouque C, De Clercq E.

Eur J Med Chem. 2008 Dec;43(12):2800-6.

·        Pubmed link

·        Pubmed ID: 18242784       

 
14) Discovery of a potent, selective and orally bioavailable 3,9-diazaspiro[5.5]undeca-2-one CCR5 antagonist

Yang H, Lin XF, Padilla F, Gabriel SD, Heilek G, Ji C, Sankuratri S, deRosier A, Berry P, Rotstein DM.

Bioorg Med Chem Lett. 2009 Jan 1;19(1):209-13.

·        Pubmed link

·        Pubmed ID: 19014885       

 
15) Inhibition of HIV Budding by a Genetically Selected Cyclic Peptide Targeting the Gag-TSG101 Interaction.

Tavassoli A, Lu Q, Gam J, Pan H, Benkovic SJ, Cohen SN.

ACS Chem Biol. 2008 Dec 19;3(12):757-64.

·        Pubmed link

·        Pubmed ID: 19053244